News

Triple Therapy Boosts HCV Response After Transplant


 

AT THE ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES

Dr. Burton disclosed that he is an investigator in a clinical trial sponsored by Vertex Pharmaceuticals, which makes telaprevir.☐

Pages

Recommended Reading

Liver Candidates Decline Many Organ Offers
MDedge Surgery
Acetaminophen Liver Failure Least Likely to Get Transplant
MDedge Surgery
Benefit of Young Liver Donors Scrutinized in Study
MDedge Surgery